Additional file 2: of The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma

Table S1. Additional hazard ratio analyses in xenograt models. Table S2 Additional hazard ratio analyses in orthotopic U251models. Table S3 Additional hazard ratio analyses in orthotopic CSCs-5model. (DOCX 23 kb)